XML 36 R25.htm IDEA: XBRL DOCUMENT v3.20.2
FAIR VALUE DISCLOSURES (Tables)
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Schedule of Face Value, Carrying Amounts and Fair Value
The following were the face values, carrying amounts and fair values of the Company’s notes payable as of June 30, 2020 and December 31, 2019, which carrying amounts generally do not approximate the fair values (in thousands):
June 30, 2020December 31, 2019
Face ValueCarrying AmountFair ValueFace ValueCarrying AmountFair Value
Financial liabilities:
Notes payable
$94,831  $94,403  $93,339  $118,481  $117,861  $119,196  
Fair Value Measurements, Recurring and Nonrecurring
As of June 30, 2020, the Company measured the following derivative instruments at fair value (in thousands):
  Fair Value Measurements Using
 Total        Quoted Prices in Active Markets 
for Identical Assets
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Recurring Basis:
Liability derivative - interest rate swaps$(3,084) $—  $(3,084) $—  
During the six months ended June 30, 2020, the Company measured the following asset(s) at fair value on a nonrecurring basis (in thousands):
  Fair Value Measurements Using
 Total        Quoted Prices in Active Markets 
for Identical Assets
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Nonrecurring Basis:
Impaired real estate (1)
$37,100  $—  $—  $37,100  
Investment in unconsolidated joint venture (1)
$528  $—  $—  $528  
_____________________
(1) Amount represents the fair value for a real estate asset or investment in unconsolidated joint venture impacted by an impairment charge during the six months ended June 30, 2020, as of the date that the fair value measurement was made. The carrying value for the real estate asset or investment in unconsolidated joint venture may have subsequently increased or decreased from the fair value reflected due to activity that has occurred since the measurement date.